Belinostat (PXD101)
Belinostat, also known as PXD101, is a novel and potent hydroxamate-type HDAC inhibitor.
Product Specifications
Background
Belinostat has been found to significantly increase the acetylation of histones H3 and H4 and exerts cytotoxicity in a wide range of tumor cell lines.
CAS Number
414864-00-9
Purity
≥ 98% by HPLC
Solubility
Soluble in DMSO
Molecular Formula
C15H14N2O4S
Shipping Conditions
Room Temperature (continental US) or Gel Packs
Storage Conditions
Store at or below –20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day.
Calculated Molecular Weight
318.4 Da
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
